ArticleFrontiers in immunology2023

CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.

Geethani Bandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.